Abstract:Objective To investigate and confirm the clinical efficacy and safety of recombinant mutant human tumor necrosis factor-NC ( rhTNF-NC,Tianenfu) injection in the treatment of malignant pleural effusion and peritoneal effusion. Methods It was a perspective,open-label,single arm and multi-center study,conducted in 82 cancer centers in China. From April 25 2013 to August 31 2015, a total of 985 patients with middle and large amount of malignant pleural effusion or peritoneal effusion were enrolled into this study. rmhTNF-NC was infused intralpeurally at a dose of 300 KU each time at d1 , d4 , d7 , or d10 , and 3-4 times was regarded as one course. The efficacy and safety were evaluated according WHO and NCI CTC AE 3. 0 criterion respectively. Results Among 985 pa-tients, the efficacy could be evaluated in 916 cases ( 93. 00%) with dropout rate of 7. 00%. In 916 patients, the objective response rate ( ORR) was 62. 44% and disease control rate ( DCR) was 97. 27%. ORR of 614 malignant pleural effusion cases and 302 malignant peritoneal effusions cases were 70. 52% and 46. 03% respectively( P<0. 05) . Two-classification Logistic regression showed that effusion position, treatment condition ( initial treatment vs. retreatment) were independent factors influencing ORR of rmhTNF-NC in the treat-ment of malignant pleural effusion or peritoneal effusion( P<0. 05) , treatment condition was the independent factor influencing ORR of rmhTNF-NC in the treatment of malignant pleural effusion ( P<0. 05) , and gender, PS score before treatment and treatment condition were independent factors influencing ORR of rmhTNF-NC in the treatment of malignant peritoneal effusion(P<0. 05). The major ad-verse effects (AE) were fever (14. 01%) and chill (10. 05%). Other AE included fatigue(1. 02%), pain(0. 81%), constipation (0. 61%), transaminase lift(0. 51%),decreased renal function(0. 30%), shortness of breath(0. 20%), rashes(0. 20%)and leuco-penia( 0. 20%) . The vast of those AE was in grade 1 or grade 2, and could be reversible. There was no grade 4 AE and drug related death happened. Conclusion rmhTNF-NC injection is effective and safe in control of malignant pleural effusions or peritoneal effu-sions, especially better in the early treat and malignant pleural effusions patients, with mild and tolerable adverse effects.

Cost-effectiveness analysis of three clinic therapeutic schemes for malignant pleural effusions

Pharmacoeconomics Evaluation of Malignant Pleural Mesothelioma

Effects of intrapleural therapy on 96 patients with malignant pleural effusion

Intrapleural treatment in patients with non‐small cell lung cancer with malignant pleural effusions in the real world

Elemene,bleomycin,as well as the two drugs in the treatment of malignant pleural effusion clinical observation

Treatment of Malignant Pleural Effusion with Radiofrequency Hyperthermia Combined with Intravenous Chemotherapy and Intrapleural Injection

Prospective, multicenter clinical study of rmhTNF-NC injection in the treatment of Chinese malignant pleural effusion or peritoneal effusion patients

Clinical Analysis of Inserting Abel Central Venous Catheter into Pleural Cavity and Interrupted Pleural Cavity Puncture to Draw Pleural Effusion in the Treatment of Patients with Malignant Pleural Effusion

Clinical Observation on Treatment of Malignant Pleural Efusion Caused by Iung Cancer with Intracavity Drainage Plus Perfusion Medication

Cost-minimization analysis of three chemotherapy schemes for non-small cell lung cancer

Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial

Clinical effect of highly agglutinative staphylococcin combined with cisplatin in treatment of malignant pleural effusion

Clinical Characteristics and Prognostic Factors in Breast Cancer with Malignant Pleural Effusion

A Meta-analysis of the clinical efficacy and safety of elemene combined cis-platinum pleural perfusion for the treatment of malignant pleural effusion

Therapeutical Effect of Intrapleural Perfusion with Hyperthermic Chemotherapy on Malignant Pleural Effusion under Video-Assisted Thoracoscopic Surgery

Intrathoracic infusion therapy with Lentinan and chemical irritants for malignant pleural effusion: a systematic review and meta-analysis of 65 randomized controlled trials

Economic Analysis and Feasibility of Ambulatory Chemotherapy for Lung Cancer

The effect of whole pleural cavity irradiation with combined 60Co and electron beam plus local biological agents on malignant pleural effusion

Efficacy Study of Hyperthermotherapy Combined with Cisplatin Injected into Thoracic Cavity in the Treatment of Pleural Effusion from Malignant Neoplams

Clinical Observation on Intrapleural Administration of Cisplatin and IL-2 Combined with Systemic Chemotherapy in the Treatment of Malignant Pleural Effusion of Lung Cancer

Investigation on the efficiency of lentinan for injection combining cisplatin on treating malignant pleural effusion based on systematic review and meta-analysis